Insurance coverage can offset this, but coverage for weight loss medications remains inconsistent
By leveraging texture and ingredient design, brands can create products that encourage mindful consumption and enhance satisfaction while meeting essential nutritional needs
The team at Metabolic Medical Center recommends vitamin B12 injections for people with a vitamin B12 deficiency
On April 1, 2026, the FDA approved orforglipron (Foundayo) by Eli Lilly for adults with obesity or overweight who also have weight-related medical problems to reduce excess body weight and maintain weight reduction long term, alongside a reduced-calorie diet and increased physical activity
Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease
Jul 31, 2024 4 min read Please note: In this article, we will refer to all medications as GLP-1s, following industry standards and consumer familiarity